Navigation Links
PATHFAST(R) Rapid Whole Blood Immunoassay Analyzer from Polymedco
Date:6/24/2009

CORTLANDT MANOR, N.Y., June 24 /PRNewswire/ -- Polymedco, Inc. is pleased to announce the introduction of the PATHFAST immunoassay analyzer, manufactured by Mitsubishi Chemical Medience Corporation, Tokyo, Japan. The PATHFAST rapid point of care system utilizes a chemiluminescent technology combined with a unique separation method using magnetic particles that allows this system to report highly accurate results that compare to large platform instruments. The PATHFAST system employs individual cartridge-based technology utilizing a whole blood sample.

The PATHFAST system can handle six samples in batch or random access mode and report these six results in 17 minutes. The PATHFAST analyzer, NTproBNP, D-Dimer and hsCRP assays have recently been 510(k) cleared by the FDA. Polymedco expects to have ten additional assays cleared shortly. The initial menu will be in the cardiac, inflammatory, and fertility area.

The PATHFAST system is a small, compact platform, which includes a computer, LCD touch screen and printer and measures W14.7" x D22.4" x H20.0". This self contained unit can easily fit on any laboratory bench. Its user friendly operation allows the technician to simply add blood to the cartridges, place them on the system and press the start button. Results will be stored, printed, and downloaded into the LIS system. This sensitive technology will allow the laboratory to report NTproBNP results from 15-30,000 pg/mL, D-Dimer results from 0.005 - 5 ug/mL FEU, and hsCRP results from 0.05 - 30 mg/L.

Polymedco, Inc. is a leading manufacturing, marketing and sales company that specializes in bringing innovative equipment and diagnostic kits to the medical market. PATHFAST is a registered mark of Mitsubishi Chemical Medience Corporation, Tokyo, Japan.

For more information, please contact Polymedco at 800-431-2123 or 914-739-5400 or visit our website: '/>"/>

SOURCE Polymedco, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. PATHFAST(R): Rapid Whole Blood Immunoassay Analyzer from Polymedco
2. Study documents rapid increase in youth bipolar disorder diagnoses
3. Rates of bipolar diagnosis in youth rapidly climbing, treatment patterns similar to adults
4. Health Insurance Premiums Rise 6.1 Percent in 2007, Less Rapidly Than in Recent Years But Still Faster Than Wages and Inflation
5. RESolutions Rapid Enrollment Solutions, LLC Mobilizes Team of Regional Recruitment Specialists(TM)
6. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
7. AWT, Inc. Continues Rapid Expansion in Middle East
8. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
9. Rapid Pathogen Screening Announces New Vice President of Corporate Relations
10. Varian Medical Systems to Introduce RapidArc(TM) Radiotherapy Technology for Volumetric Arc Therapy at ASTRO 2007
11. Varian Medical Systems to Unveil RapidArc(TM) Volumetric Arc Therapy and Other Products Designed to Speed Delivery of Precision Radiotherapy and Brachytherapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... , , WASHINGTON, Nov. 21 /PRNewswire-USNe...wing statement after the Senate voted to begin ful...,, (Logo: http://www.newscom.com/cgi-bin/prnh/... another historic step on the road to enacting hea...dural hurdle, senators will now have an opportunit...
(Date:11/21/2009)... , , WASHINGTON, Nov. 21 /PRNewswire-USN...1990s to eliminate onchocerciasis (river blindness...evalence of the disease in recent years, as eviden... requiring mass drug administration in six endemic...th annual meeting of the American Society of Tropi...
(Date:11/21/2009)... , NH based medical crede... first in its industry to form a partnerhsip with ...he U.S. This partnership will help to transform q... (Vocus) November 21, 2009 -- IS... has announced a new agreement with Amerinet Inc.,...
(Date:11/21/2009)... , Eric J. Hall, presiden...oundation of America (AFA) issued the following st...rment detection as part of the new annual wellness...rotection and Affordable Care Act" that was i...ew York, NY (PRWEB) November 21, 2009 -- Eric J. H...
(Date:11/20/2009)... , , Pioneering Neurologist Closer to Unde...ON, Nov. 20 Dr. Jeremy ...cal School and neurologist at the Massachusetts Ge..., presented his laboratory,s research on the new f...of the MINDlink Foundation. ,, Dr. Schmahmann i...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
...obstructive sleep apnea, a sleep disorder that cau...s a night and appears to also promote bed-wetting ...sociate professor of pediatrics at the University ...lems at night, 66 children (41 percent) were also ...
...nstant stress can make people sick, and now a team...ocused on 119 men and women who were taking care o...ers was compared with that of 106 people of simila...blood of the stressed caregivers compared with blo...
...ive findings in a new study that looked at the rol... medical errors involving medications. The inves...e in medical rounds with doctors resulted in t...in the hospital, an area where previous studies ha...
...appears to prevent or delay the onset of prostate ...he growth of high-grade cancers. More than 18,...teride 5 mg/day or placebo. At baseline, digital r... the finasteride group treated for 7 years, prosta...
...rbilt University shows cholesterol-lowering effect...tea. The study is the first placebo-controlled cli...operties of tea in humans. Studies of large po...nship between tea and lower levels of cholesterol ...
...the ongoing Nurses Health Study II suggest women w...ach day may decrease their risk of developing type...intake has produced conflicting results, with most...a positive effect //because alcohol increases insu...
Other Medicine News:Health News:Sleep Apnea Linked to Bed-Wetting in Kids 2
(Date:11/20/2009)... , NEW YORK, Nov. 20 Report...port is available in its catalogue. ,, Pipette..., http://www.reportlinker.com/p0164373/Pipett...tm_source=prnewswire&utm_medium=pr&utm_cam...e treated as an integral part of any research labo...
(Date:11/20/2009)... , NEW YORK, Nov. 20 ,, ...rch report is available in its catalogue. ,, G..., http://www.reportlinker.com/p0164741/Global-Ma...ce=prnewswire&utm_medium=pr&utm_campaign=p...opsy devices includes the spring loaded core needl...
(Date:11/20/2009)... , NEW YORK, Nov. 20 Report...port is available in its catalogue. ,, Medical..., http://www.reportlinker.com/p0164242/Medical-A...m_source=prnewswire&utm_medium=pr&utm_camp...es and sealants is gaining preeminence in medical ...
Breaking Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Sevocity EHR 08 Released With ARRA 28Stimulus 29 Commitment 13737 1Sevocity EHR 08 Released With ARRA 28Stimulus 29 Commitment 13737 2Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 1Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 2Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 3Sundia Receives the Highest Growth Potential Award from Zhangjiang 55681 1Sundia Receives the Highest Growth Potential Award from Zhangjiang 55681 2
...SAN FRANCISCO, Dec. 17 Medivation, Inc.,(Nasdaq: ...ient enrollment in a,Phase 1-2 dose-escalation cli...r antagonist, in castration-resistant prostate can...the U.S. Food and Drug Administration (FDA) to,adv... The open-label, U.S. Phase 1-2 study evaluated pr...
...EMERYVILLE, Calif., Dec. 17 Neurobiological,Techn...ounced that an independent,Data Safety Monitoring ...cal,trials of Viprinex(TM) for the treatment of ac...As a result, the company has terminated further en...e the data before evaluating the,potential for any...
Other Medicine Technology:Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis 2
...g; 96 and E-Gel® 48 gels run in the specially ...h combine the base and power supply in one device.... mother E-Base™ and to other daughter E-Base...esis of two or more E-Gel® 96 or E-Gel® 48...
...lder™ Platform is designed with a spring-loa... E-Gel® 48 gel cassettes stay firmly in place ...lacement and loading from one gel to the next with...g software. In addition, the E-Holder™ Platf...
...units can be used for: Analytical Protein and Pept...g SDS-PAGE gels IEF in ultrathin PAGE gels (Z64,07... Peptide Separation: Non-denaturating PAGE gels an...071-9& Z64,075-1) Molecular Biology: DNA/RNA fragm...
...set up and safe to use, the Gel XL Ultra includes ...garose gels. The unit is compact, requiring a mini...r supply eliminates a tangled mess of leads and co...ety and convenience, the power supply can detect w...
Medicine Products: